Overview Request Sample Pages Request Customization Download PDF
You are viewing: Japan Defibrillator Market analysis
Part of: Defibrillator Market (Global)

The Japan Defibrillator Market was valued at $464.15 Million in 2025 and projected to reach to $655.55 Million by 2030, representing a compound annual growth rate of 7.1%. Japan's defibrillator market is positioned for robust growth through 2030, expanding from USD 464.15 million to USD 655.55 million.

Japan Defibrillator Market Trends and Insights

  • Japan's aging population and rising prevalence of cardiovascular diseases are driving demand for both automated external defibrillators (AEDs) and implantable cardioverter-defibrillators (ICDs).
  • The country's advanced healthcare infrastructure and strong regulatory framework support market expansion through 2030. Japan's defibrillator market benefits from increasing public awareness campaigns and government initiatives to improve sudden cardiac arrest survival rates.
  • Japan has been investing in AED deployment across public spaces, workplaces, and transportation hubs, which accelerates market penetration.
  • The forecast period through 2030 anticipates sustained growth driven by technological innovations, improved reimbursement policies, and Japan's commitment to enhancing emergency cardiac care capabilities..

Key Market Statistics

  • CAGR (2025-2030) 7.1% CAGR
  • Market Size, 2025 ~USD 464.15 Million
  • Forecast, 2030 ~USD 655.55 Million
  • Country Japan

Japan Defibrillator Market Overview

Aging Population Driver :

Japan's rapidly aging demographic, with over 29% of the population aged 65+, is significantly increasing cardiovascular disease prevalence and creating sustained demand for defibrillator solutions across healthcare facilities and public spaces.

Strong CAGR Performance :

Japan's defibrillator market is growing at 7.1% CAGR through 2030, outpacing the global growth rate of 6.5%, driven by technological advancement and increased healthcare investment in cardiac care infrastructure.

AED Public Access Expansion :

Japan has implemented extensive AED deployment programs in public spaces, transportation hubs, and commercial facilities, with government initiatives supporting accessibility and training to improve sudden cardiac arrest survival rates.

Advanced ICD Technology Adoption :

Japanese healthcare providers are increasingly adopting sophisticated implantable cardioverter-defibrillators with remote monitoring capabilities, supported by strong reimbursement policies and integration with Japan's advanced healthcare system.

Japan Defibrillator Market Dynamics

  • The aging population combined with rising cardiovascular disease incidence creates sustained demand for both automated external defibrillators in public settings and advanced implantable devices in clinical environments.
  • Government health initiatives and reimbursement support further accelerate market expansion. Technological innovations in remote monitoring, miniaturization, and battery longevity are enhancing product appeal among Japanese healthcare providers.
  • Increased awareness campaigns and mandatory AED placement regulations in public facilities continue to drive adoption.
  • The market benefits from Japan's sophisticated healthcare infrastructure, high disposable income, and strong emphasis on preventive cardiac care, positioning it as a key growth market in the Asia-Pacific region..

Related Ecosystem

Cardiovascular Devices

Top Technologies
  • External Defibrillators
  • Implantable Cardioverter Defibrillators
  • Pulse Oximeters
  • Robotic Systems
  • 3-Lead ECG Leadwires
Top Companies
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Terumo Corporation
  • KONINKLIJKE PHILIPS N.V.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • Japan's defibrillator market is valued at USD 464.15 million in 2025 and will reach USD 655.55 million by 2030 at a 7.1% CAGR.
      • Japan's aging demographic and high cardiovascular disease burden are primary growth catalysts for defibrillator adoption.
      • Japan's government-backed AED deployment initiatives in public spaces significantly expand market accessibility and penetration.
      • Technological advancements and improved reimbursement in Japan are expected to sustain market growth through 2030.

      Defibrillator Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment EXTERNAL DEFIBRILLATORS (Product)
      Forecast Period 2025–2030
      Growth Rate CAGR of 6.5% from 2025 to 2030
      Largest Segment IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (Product)
      Market Size Base Year (Billions) ~USD 12 (2025)
      Revenue Forecast (Billions) ~USD 16.44 (2030)
      Segments Covered Product, Type, Patient Type, End User

      Japan Defibrillator Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Product

      • External Defibrillators
      • Implantable Cardioverter Defibrillator
      • Implantable Cardioverter Defibrillators

      By Type

      • Automated External Defibrillators
      • Biventricular Icds/Cardiac Resynchronization Therapy Defibrillators
      • Dual-Chamber Icds
      • Fully Automated Defibrillators
      • Fully Automated External Defibrillators
      • Manual External Defibrillators
      • Semi- Automated Defibrillators
      • Semi-Automated External Defibrillators
      • Single-Chamber Icds
      • Subcutaneous Implantable Cardioverter Defibrillators
      • Transvenous Implantable Cardioverter Defibrillators
      • Wearable Cardioverter Defibrillators

      By Patient Type

      • Adult Patients
      • Pediatric Patients

      By End User

      • Cardiac Centers
      • Home Care Settings
      • Hospitals & Clinics
      • Other End Users
      • Prehospital Settings
      • Public-Access Market
      • Public-Access Markets

      Target Audience

      • Medical Device Manufacturers : Defibrillator and cardiac device manufacturers need Japan-specific market data to develop localized product strategies, assess competitive positioning, and identify growth opportunities in this high-value healthcare market with unique regulatory requirements.
      • Healthcare Facility Administrators : Hospital and clinic administrators require market insights to justify capital investments in defibrillator equipment, understand procurement trends, and align cardiac care infrastructure with Japan's evolving healthcare standards and aging population needs.
      • Investment & Private Equity Firms : Investors evaluating opportunities in Japan's healthcare sector need comprehensive market data on defibrillator market size, growth trajectory, and profitability drivers to make informed investment decisions and identify acquisition targets.
      • Healthcare Consultants & Advisors : Consulting firms advising healthcare organizations and medical device companies require Japan-specific market intelligence to develop strategic recommendations, competitive analyses, and market entry strategies tailored to local conditions.
      • Government & Policy Makers : Japanese health ministry officials and policy makers need market data to evaluate healthcare infrastructure investments, assess public AED deployment effectiveness, and develop evidence-based cardiac care policies for the aging population.

      Key Companies in the Japan Defibrillator Market

      CompanyHQOwnershipStrongest segments
      KINDRED HEALTHCARE INC.United StatesPrivate CompanyInjectable and infusion-related utilization,Oral drug regimen management,Topical and transdermal administration,
      SORIN GROUPItalyPrivate CompanyCardiac surgery capital equipment (heart-lung machines, autotransfusion systems),Cardiac surgery disposables (oxygenators, circuits, autotransfusion sets),Heart valves and repair devices (mechanical, tissue, structureless, annuloplasty rings),
      AT&SCanadaPublic CompanyTurnkey automation systems (design, build, commissioning),Lifecycle and post-automation services,Software and digital solutions,
      CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic sports medicine & Hall power tools,General surgery: AirSeal, Buffalo Filter, endomechanical,Endoscopic technologies (GI) and therapeutic devices,
      MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Medical Surgical Portfolio (incl. patient monitoring & diabetes),Neuroscience Portfolio,
      BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiac Rhythm Management and Electrophysiology,Structural Heart and LAAC (WATCHMAN FLX and related),Interventional Cardiology and Peripheral Vascular,
      ABBOTTUnited StatesPublic CompanyMedical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, molecular, point-of-care, rapid tests),Nutritional Products (pediatric, adult, infant formula),
      ASAHI KASEI CORPORATIONJapanPublic CompanySemiconductor and electronics materials (Pimel, Sunfort, Novacure, glass fabric, sensors),Battery separators and energy-related membranes (Hipore, Celgard, Aqualyzer, Aciplex, Microza),Healthcare products and pharma (prescription drugs, virus filters, wearable defibrillators, ICU systems),
      STRYKERUnited StatesPublic CompanyOrthopaedics (joints, trauma, extremities, Mako-linked implants),MedSurg equipment and patient handling/safety,Neurotechnology and stroke/venous therapies,
      KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnostic Imaging (MRI, CT, Ultrasound, X-ray),Image Guided Therapy (systems and devices),Connected Care (Monitoring & Enterprise Informatics),
      MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices (coronary stents, balloons, accessories),Orthopedics Devices (reconstructive joints, spine, trauma),Cardiac Rhythm Management (defibrillators, CRT, pacemakers),
      NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitoring & clinical information systems,Physiological measuring & neurodiagnostics (EEG/EMG/EP/ECG),Therapeutic devices (defibrillators, AEDs, ventilators, anesthesia, pacemakers, chest compression),
      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.ChinaPublic CompanyPatient Monitoring, Anesthesia, Ventilation, and Defibrillation (incl. M-connect solutions),Ultrasound and Radiology / Medical Imaging,In-vitro Diagnostics (CLIA, Chemistry, Hematology),
      CU MEDICAL SYSTEMS CO., LTD.South KoreaPublic CompanyAutomatic External Defibrillators (AEDs),Automated CPR Devices,Heart Rate Monitors and Functional Electrical Stimulation,
      MEDIANA CO, LTD.South KoreaPublic CompanyPatient monitors & vital signs monitors,AEDs & monitor/defibrillators,Fetal products & physio modules,

      KINDRED HEALTHCARE INC.

      Kindred Healthcare Inc. is a private healthcare company founded in 1985 in the United States with 64,200 employees. The company operates as a major healthcare services provider in the U.S. market.

      SORIN GROUP

      Sorin Group is an Italian private company founded in 2004 with 3,940 employees. The company operates in the healthcare sector in Italy.

      AT&S

      AT&S is a Canadian public company founded in 1978 with 7,000 employees. The company operates in Canada's business sector.

      CONMED CORPORATION

      CONMED Corporation is a U.S. public company founded in 1970 with 3,900 employees. The company operates in the medical device and healthcare equipment industry.

      MEDTRONIC

      Medtronic is a public company founded in 1949 in Ireland with 95,000 employees. The company is a major global medical technology and healthcare solutions provider.

      BOSTON SCIENTIFIC CORPORATION

      Boston Scientific Corporation is a U.S. public company founded in 1979 with 59,000 employees. The company is a leading developer and manufacturer of medical devices and healthcare solutions.

      ABBOTT

      Abbott is a U.S. public company founded in 1888 with 115,000 employees. The company is a diversified healthcare and pharmaceutical company with a global presence.

      ASAHI KASEI CORPORATION

      Asahi Kasei Corporation is a Japanese public company founded in 1922 with 47,895 employees. The company operates across multiple sectors including healthcare and materials.

      STRYKER

      Stryker is a U.S. public company founded in 1941 with 56,000 employees. The company is a leading medical technology company specializing in orthopedic and surgical products.

      KONINKLIJKE PHILIPS N.V.

      Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees. The company is a global diversified technology company with significant healthcare and lighting divisions.

      MICROPORT SCIENTIFIC CORPORATION

      MicroPort Scientific Corporation is a Chinese public company founded in 1998 with 6,547 employees. The company operates in the medical device and healthcare sector.

      NIHON KOHDEN CORPORATION

      Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees. The company manufactures medical equipment and healthcare devices.

      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

      Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a Chinese public company founded in 1991 with 21,288 employees. The company is a leading manufacturer of medical devices and healthcare equipment.

      CU MEDICAL SYSTEMS CO., LTD.

      CU Medical Systems Co., Ltd. is a South Korean public company founded in 2001 with 118 employees. The company operates in the medical device sector.

      MEDIANA CO, LTD.

      Mediana Co, Ltd. is a South Korean public company founded in 1993 with 160 employees. The company operates in the healthcare and medical device industry.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise market valuation data for Japan (USD 464.15M in 2025) with verified 7.1% CAGR projections through 2030, enabling accurate financial forecasting and investment decision-making specific to the Japanese market.
      • Competitive Landscape Intelligence : Understand Japan-specific competitive dynamics, market share distribution among local and international defibrillator manufacturers, and identify strategic positioning opportunities within this high-growth Asian market.
      • Regulatory & Reimbursement Insights : Access detailed analysis of Japan's healthcare reimbursement policies, regulatory requirements for AED and ICD devices, and government initiatives driving market adoption to inform market entry and product development strategies.
      • Demographic & Clinical Trends : Leverage Japan-specific data on aging population impact, cardiovascular disease prevalence, hospital infrastructure, and clinical adoption patterns to tailor product offerings and marketing strategies for maximum market penetration.
      • Strategic Partnership Opportunities : Identify key distribution channels, hospital networks, and healthcare provider segments in Japan to establish partnerships, optimize go-to-market strategies, and accelerate revenue growth in this premium healthcare market.

      Frequently asked questions

      What is the current size of Japan's defibrillator market?

      Japan's defibrillator market is valued at USD 464.15 million in 2025.

      What is the projected market size for Japan's defibrillator market by 2030?

      Japan's defibrillator market is projected to reach USD 655.55 million by 2030.

      What is the CAGR for Japan's defibrillator market?

      Japan's defibrillator market is expected to grow at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2030.

      What factors are driving growth in Japan's defibrillator market?

      Japan's defibrillator market growth is driven by an aging population, rising cardiovascular disease prevalence, government AED deployment initiatives, and technological innovations.

      How is Japan's healthcare infrastructure supporting defibrillator market expansion?

      Japan's advanced healthcare infrastructure, strong regulatory framework, and government-backed public awareness campaigns support widespread defibrillator adoption and market expansion.

      RESEARCH METHODOLOGY

      This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

      Secondary Research

      The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US Census Bureau, ), World Health Organization (WHO), World Bank, Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Health Canada, European Medicines Agency (EMA), Medicines and Healthcare Products Regulatory Agency (MHRA, UK), American College of Cardiology (ACC), American Heart Association, Centers for Medicare & Medicaid Services (CMS) were referred to identify and collect information for the global defibrillator market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the pulse oximeters market. The primary sources from the demand side include key executives from hospitals, physicians, clinicians, and research institutes.

      A breakdown of the primary respondents is provided below:

      Defibrillator Market

      Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

      Note 2: Others include sales, marketing, and product managers.

      Note 3: Tiers are defined based on a company’s total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      All major product manufacturers offering various defibrillators were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value defibrillator market was also split into various segments and subsegments at the region and country level based on:

      • Product mapping of various manufacturers for each type of defibrillator market at the regional and country level 
      • Relative adoption pattern of each defibrillator market among key end-user segments at the regional and/or country level 
      • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
      • Detailed secondary research to gauge the prevailing market trends at the regional and/or country level 

      Global Defibrillator Market: Top-Down & Bottom Approach

      Defibrillator Market

      Data Triangulation

      After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the defibrillator industry.

      Market Definition

      A defibrillator is a device that monitors the heart rhythm and delivers electric shocks upon detecting an abnormal heart rhythm to restore the normal heart rhythm. The device plays an important role in the management and treatment of sudden cardiac arrest.

      Stakeholders

      • Manufacturers of Defibrillators
      • Distributors of Defibrillators
      • Hospitals, Clinics, Cardiac Centers
      • Non-government Organizations
      • Government Regulatory Authorities
      • Contract Manufacturers and Third-party Suppliers
      • Research Laboratories and Academic Institutes
      • Clinical Research Organizations (CROs)
      • Government and Non-governmental Regulatory Authorities

      Report Objectives

      • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To define, describe, segment, and forecast the defibrillator market by product, patient type, end user, and region
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall defibrillator market
      • To forecast the size of the defibrillator market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile key players in the defibrillator market and comprehensively analyze their core competencies and market shares
      • To track and analyze competitive developments, such as acquisitions, product launches, expansions, collaborations, agreements, & partnerships, and R&D activities of the leading players in the defibrillator market
      • To benchmark players within the defibrillator market using the competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

      Get the Full Defibrillator Market Report

      Full forecast, segment splits, and company analysis for all Defibrillator Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status